Language: 简体中文 English
Your location: Home > Program
Query:
Date:
  • All
  • November 19, 2026
  • November 20, 2026
  • November 21, 2026
Hall:
  • All
  • 5th‑Floor Grand Ballroom
  • S101
  • S102
  • S103
  • S105
  • S106
  • S107
  • S109
  • S110
  • S111
  • S201
  • S202
  • S203
  • S204
  • S205
  • S206
  • S207
  • V11
  • V22
  • V23
  • V24
  • V25
  • InterContinental Ballroom 1
Subject:
  • All
  • Plenary Session
  • Oncology
  • Minimally Invasive Surgery
  • Stones
  • Incontinence
  • Robotic Surgery
  • Clinical Research
  • Basic and Translational Science
  • Female Urology
  • Andrology
  • Nursing
  • Infection
  • Renal Transplantation
  • Laser Surgery
  • Community Urology
  • Reconstructive Surgery
  • Adrenals
  • Pediatric Urology
  • Smart Surgery
  • Urological Engineering
  • Special Session
  • Prostate Cancer Pathfinders: Evidence into Action
  • Prostate Neoplasms Session
  • Benign Diseases Diagnosis & Treatment Session
  • Urolithiasis Standardized Care Project
  • Discovering Urological Frontiers
  • Urology & Prostate
  • Rising Leaders Urology
  • Urologic Oncology Session
  • Training Program for Urological Department
  • Precision Care in Urologic Oncology
  • Uro-Oncology Leadership & Innovation Forum
  • Remote Session: Normalized Surgical Practice
  • RCC Immunotherapy Session
  • Intelligent Leadership in Prostate Care
  • Bladder Cancer Session
  • MP + SP in URO Seminar
  • Benign Prostatic Hyperplasia Session
  • Ingenuity Exploration
  • Renal Cell Carcinoma Session
  • Prostate Cancer Session

November 19, 2026

S111

November 19, 2026 15:00-15:25 Opening Remarks Uro-Oncology Leadership & Innovation Forum
Moderator :
1 15:00-15:25

Opening Remarks

Jian Huang China
Jianye Wang China
Zhangqun Ye China
Xu Zhang China
Ping Zhao China
November 19, 2026 15:25-16:25 Advancing Care, Redefining Standards Uro-Oncology Leadership & Innovation Forum
1 15:25-15:45

From Evidence to Clinical Practice: Interpretation of the Expert Guidance on the Clinical Use of Enfortumab Vedotin in Urothelial Carcinoma

Xiaoping Zhang China
2 15:45-16:05

Redefining First-Line Treatment: Enfortumab Vedotin Combination Therapy as a New SoC for La/mUC

Hailong Hu China
3 16:05-16:25

Redefining UC Care: Evolving Treatment Landscape and New Perspectives on Patient Management

Jinhai Fan China
November 19, 2026 16:20-16:50 Discussion Uro-Oncology Leadership & Innovation Forum
1 16:25-16:50

Discussion

Liangkuan Bi China
Minfeng Chen China
Liangyou Gu China
Ju Guo China
Dexuan Gao China
Hailong Hu China
Jia Hu China
Qiang Lv China
Yijun Shen China
Qi Tang China
Yang Yan China
November 19, 2026 16:55-17:30 Beyond Survival, Leading the Future Uro-Oncology Leadership & Innovation Forum
1 16:50-17:10

Exploring current perceptions in mHSC: myths, evidence, and practice

Yonghong Li China
2 17:10-17:30

Shaping the Future: The Evolving Landscape of Prostate Cancer Treatment

Hao Ceng China
November 19, 2026 17:30-17:55 Discussion Uro-Oncology Leadership & Innovation Forum
1 17:30-17:55

Discussion

Jiangang Chen China
Di Gu China
Yanjiang Li China
Zhongjie Qiao China
Shaoxi Niu China
Peng Wu China
Yudong Wu China
Yong Yang China
Junlong Zhuang China
November 19, 2026 17:55-18:00 Summary Uro-Oncology Leadership & Innovation Forum
1 17:55-18:00

Summary

Jian Huang China
Jianye Wang China
Zhangqun Ye China
Xu Zhang China